Connection
Edward Havranek to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Edward Havranek has written about Diabetes Mellitus, Type 2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.200 |
|
|
|
-
Havranek EP, Esler A, Estacio RO, Mehler PS, Schrier RW. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial. Am Heart J. 2003 Jun; 145(6):993-8.
Score: 0.086
-
Ritchie ND, Christoe-Frazier L, McFann KK, Havranek EP, Pereira RI. Effect of the National Diabetes Prevention Program on Weight Loss for English- and Spanish-Speaking Latinos. Am J Health Promot. 2018 03; 32(3):812-815.
Score: 0.056
-
Lipska KJ, Wang Y, Kosiborod M, Masoudi FA, Havranek EP, Krumholz HM, Inzucchi SE. Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):236-42.
Score: 0.035
-
Hockensmith ML, Estacio RO, Mehler P, Havranek EP, Ecder ST, Lundgren RA, Schrier RW. Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes. J Card Fail. 2004 Apr; 10(2):126-31.
Score: 0.023